Neuroscience
An article from the Australian website, The Age:
- "ace Mobile": An Application For Dementia Evaluations (...in Neuropsychology? ...in General Practice? ...?)
A curious development for those interested in neuropsychological assessment and in assessment related to dementia, as a not-for-profit company released on the 9th of July a free mobile application that is a version of Addenbrooke's Cognitive Examination.Here...
- Business World: R&d Spending
A report from BusinessWeek from 27 August 2009: Drug, Biotech Research Spending Hangs Tough Overall U.S. corporate R&D spending is down 4% since the end of 2007, but some companies have chosen to buck the trend By Emily Thornton and Frederick Jespersen...
- Business World: "the Brain Industry"
From The Seattle Times:Biotech Watch: Biotech companies scramble to develop brain-related products By Steve Johnson Knight Ridder Newspapers The Seattle Times Monday, July 25, 2005 SAN JOSE, Calif. — The prospect of a billion people nearing the age...
- Tysabri (natalizumab): Another Case Of Pml
A third case of progressive multifocal leukoencephalopathy (PML), as reported via The New York Times website: M.S. Drug Tied to a Death Published: March 31, 2005 By Bloomberg News Biogen Idec and the Elan Corporation said that a third patient had developed...
- Pharmaceutical Clinical Trials: Merck
From The New York Times (06 September 2004; free registration required): Merck Says It Will Post the Results of All Drug Trials By GARDINER HARRIS Merck & Company says it will post the results of its clinical trials on drugs on a Web site run by...
Neuroscience
Business World: Australia's CogState
An article from the Australian website, The Age:
CogState promotes brain tests to draw takeover offers
By Rebecca Urban
September 22, 2004
Frustrated by its diminishing value on the Australian sharemarket, diagnostic maker CogState is pitching itself to some of the world's leading pharmaceutical companies as a potential takeover target.
Just seven months after the company's public listing, chief executive Peter Bick told The Age that he had become impatient with the lack of trading in its shares and selling the business might be the only way to recoup lost value for shareholders.
Dr Bick would not confirm which companies he was talking to. But pharmaceutical giants Pfizer, Johnson & Johnson and Lundbeck are believed to be high on the hit-list given they are the only companies worldwide to have Alzheimer's disease drugs approved for the market.
CogState's computerised brain test helps diagnose Alzheimer's by alerting doctors to changes in a patient's cognitive function and can help verify whether a patient is responding to prescribed medication.
Dr Bick will travel to the US next week to meet several drug companies and plans to emphasise the value of the test as a marketing tool for their products.
[ ... Read the full article ... ] (free registration required)
- "ace Mobile": An Application For Dementia Evaluations (...in Neuropsychology? ...in General Practice? ...?)
A curious development for those interested in neuropsychological assessment and in assessment related to dementia, as a not-for-profit company released on the 9th of July a free mobile application that is a version of Addenbrooke's Cognitive Examination.Here...
- Business World: R&d Spending
A report from BusinessWeek from 27 August 2009: Drug, Biotech Research Spending Hangs Tough Overall U.S. corporate R&D spending is down 4% since the end of 2007, but some companies have chosen to buck the trend By Emily Thornton and Frederick Jespersen...
- Business World: "the Brain Industry"
From The Seattle Times:Biotech Watch: Biotech companies scramble to develop brain-related products By Steve Johnson Knight Ridder Newspapers The Seattle Times Monday, July 25, 2005 SAN JOSE, Calif. — The prospect of a billion people nearing the age...
- Tysabri (natalizumab): Another Case Of Pml
A third case of progressive multifocal leukoencephalopathy (PML), as reported via The New York Times website: M.S. Drug Tied to a Death Published: March 31, 2005 By Bloomberg News Biogen Idec and the Elan Corporation said that a third patient had developed...
- Pharmaceutical Clinical Trials: Merck
From The New York Times (06 September 2004; free registration required): Merck Says It Will Post the Results of All Drug Trials By GARDINER HARRIS Merck & Company says it will post the results of its clinical trials on drugs on a Web site run by...